ONO-4538 Phase I Study in Patients With Solid Tumor

NCT02261285 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Advanced Solid Tumors
Recurrent Solid Tumors

Interventions

DRUG: ONO-4538

Sponsor

Ono Pharmaceutical Co., Ltd.